Aclarion SG&A Expenses 2021-2024 | ACON
Aclarion sg&a expenses from 2021 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
| Aclarion Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024 | $5 |
| 2023 | $4 |
| 2022 | $4 |
| 2021 | $2 |
| 2020 | $1 |
| Aclarion Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024-12-31 | $2 |
| 2024-09-30 | $1 |
| 2024-06-30 | $1 |
| 2024-03-31 | $1 |
| 2023-12-31 | $1 |
| 2023-09-30 | $1 |
| 2023-06-30 | $1 |
| 2023-03-31 | $1 |
| 2022-12-31 | $1 |
| 2022-09-30 | $1 |
| 2022-06-30 | $2 |
| 2022-03-31 | $1 |
| 2021-12-31 | $1 |
| 2021-09-30 | $1 |
| 2021-06-30 | $0 |
| 2021-03-31 | $0 |
| 2020-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.004B | $0.000B |
| Aclarion Inc. is a healthcare technology company which leverages Magnetic Resonance Spectroscopy and a proprietary biomarker to optimize clinical treatments. The Company is also researching the application of AI and machine learning platforms to analyze both the raw spectroscopy data and the post-processed signal to evaluate whether AI platforms. Aclarion Inc. is based in SAN MATEO, CA. | |||